Maryland House Bill HB813

Maryland 2023 Regular Session

• Introduced: 2/8/23
• Refer: 2/8/23

Caption

Maryland Medical Assistance Program – Prescription Digital Therapeutics

Impact

The bill extends the range of treatment options available under the Maryland Medical Assistance Program, potentially improving health outcomes for vulnerable populations. By covering prescription digital therapeutics, which are software-based treatments that can be utilized in conjunction with traditional care, the state aims to enhance access to effective interventions for those suffering from mental health and addiction issues. This initiative could also help alleviate the burden on state-funded healthcare systems by potentially reducing long-term healthcare costs associated with untreated substance use disorders and mental health issues.

Summary

House Bill 813 is a pivotal piece of legislation aimed at reforming the Maryland Medical Assistance Program by mandating coverage for prescription digital therapeutics. These therapeutics include various digital health technologies approved by the FDA for the treatment of medical conditions, specifically targeting individuals diagnosed with substance use disorders and depression. The inclusion of these products represents a significant shift toward integrating technology in mental health care and substance abuse treatment within the state's healthcare framework.

Contention

Notably, discussions surrounding the bill highlight some contention regarding the adequacy of coverage, the effectiveness of digital therapeutics compared to traditional methods, and the necessary regulatory oversight. Critics may express concern over whether the inclusion of digital therapeutics will provide sufficient support to individuals who prefer conventional therapy methods or may lack access to technology. Ensuring that these digital solutions are applied appropriately and reach the intended recipients remains a critical aspect of the bill's implementation and success.